TrialMedicine2018

Efficacy and safety of recombinant human parathyroid hormone (1-34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis.

Jing Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.